Diabetes Drug Acarbose May Calm Severe Allergies By Reshaping Gut Bacteria
Graded Preliminary — mouse and cell work with a supporting human cohort analysis of unreported size, yet the mechanism has not been tested in people and the human link is observational only.
- Design
- —
- Participants
- —
- Duration
- —
- Funding
- MEXT | Japan Society for the Promotion of Science (JSPS); Japan Agency for…
This study hints that gut bacteria metabolites like succinate may shape allergic responses.
In mice, the diabetes drug acarbose changed how gut bacteria use carbs, boosting a microbe that produces succinate. That succinate then blocked the mast cell reactions behind severe allergic shock. A look at human records found people taking similar drugs had fewer anaphylaxis cases.
Disclaimer: Research summaries are provided for informational purposes only and do not constitute medical advice. Always consult a qualified healthcare professional before making changes to your health routine.